 <h1>AfterPlan Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>levonorgestrel</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about levonorgestrel. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name AfterPlan.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to levonorgestrel: oral tablet</i></p><p>Other dosage forms:</p><ul><li>intrauterine insert extended release</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, levonorgestrel (the active ingredient contained in AfterPlan) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking levonorgestrel:</p><p>
<i>More common</i>
</p><ul>
<li>Heavy or light menstrual bleeding</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Absent missed or irregular menstrual periods</li>
<li>cramps</li>
<li>irregular menstruation</li>
<li>pain</li>
<li>pain in the pelvis</li>
<li>stopping of menstrual bleeding</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of levonorgestrel may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>dizziness</li>
<li>headache</li>
<li>nausea</li>
<li>tenderness of the breasts</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Diarrhea</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levonorgestrel: intrauterine device, oral tablet, subcutaneous implant</i></p><h3>General</h3><p>The most commonly reported adverse effects are alterations of menstrual bleeding patterns, nausea, abdominal/pelvic pain, headache/migraine, dizziness, fatigue, amenorrhea, ovarian cysts, genital discharge, acne/seborrhea, breast tenderness, and vulvovaginitis.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Irregular menstrual bleeding (67%), infrequent menstrual bleeding (up to 57%), ovarian cyst (31.2%), menstrual changes (up to 31.9%), decreased uterine bleeding (23.4%), prolonged menstrual bleeding (22%), vulvovaginitis (20.2%), amenorrhea (18.4%), genital discharge (up to 14.9%), heavier menstrual bleeding (13.8%),vaginal infections (13.6%), vulvovaginal infections (13.3%), lighter menstrual bleeding (12.5%), increased scheduled uterine bleeding (11.9%), breast tenderness (10.7%)</p>
<p><b>Common</b> (1% to 10%): Dysmenorrhea, breast pain/discomfort, upper genital tract infection, genital tract bleeding, pelvic inflammatory disease, endometritis, dyspareunia, pelvic discomfort/pain, delay of menses more than 7 days, vaginal discharge, bleeding not related to menses</p>
<p><b>Uncommon</b> (0.1% to 1%): Uterine spasm, cervicitis/Papanicolaou smear normal class II, change in vaginal secretion</p>
<p><b>Rare</b> (less than 0.1%): Uterine perforation</p>
<p><b>Frequency not reported</b>: Breast enlargement, vaginal candidiasis, changes in cervical erosion, changes in cervical secretion, ectopic pregnancy</p>
<p><b>Postmarketing reports</b>: Oligomenorrhea, irregular menstruation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.1%), abdominal/pelvic pain (up to 22.6%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Abdominal distension</p>
<p><b>Frequency not reported</b>: Bloating, abdominal cramps<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (16.9%)</p>
<p><b>Common</b> (1% to 10%): Partial/complete IUS expulsion, weight increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Edema, change in body weight</p>
<p><b>Very rare</b> (less than 0.01%): Face edema</p>
<p><b>Frequency not reported</b>: Decreased weight, sepsis, group A streptococcal sepsis</p>
<p><b>Postmarketing reports</b>: IUS breakage, procedural bleeding<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16.8%), dizziness (11.2%)</p>
<p><b>Common</b> (1% to 10%): Migraine</p>
<p><b>Postmarketing reports</b>: Stroke, syncope, IUS insertion related vasovagal reaction or seizure<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression/depressed mood, mood changes, mood swings, decreased libido, nervousness</p>
<p><b>Frequency not reported</b>: Changes in libido<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Acne/seborrhea (15%)</p>
<p><b>Common</b> (1% to 10%): Alopecia, hirsutism</p>
<p><b>Uncommon</b> (0.1% to 1%): Pruritus, eczema, pigmentation changes/hyperpigmentation</p>
<p><b>Rare</b> (less than 0.1%): Rash, urticaria</p>
<p><b>Frequency not reported</b>: Chloasma, melasma</p>
<p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Increased blood pressure, arterial/venous thrombotic events, pulmonary emboli, deep vein thrombosis, stroke<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Benign/malignant liver tumors</p>
<p><b>Postmarketing reports</b>: Breast cancer<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Contact lens intolerance<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Allergic reaction</p>
<p><b>Postmarketing reports</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Kyleena (levonorgestrel)." Bayer Pharmaceutical Inc, West Haven, CT. </p><p id="ref_2">2. "Product Information. Mirena (levonorgestrel)." Berlex Laboratories, Richmond, CA. </p><p id="ref_3">3. "Product Information. Plan B (levonorgestrel)." Women's Capital Corporation, Bellevue, WA. </p><p id="ref_4">4. "Product Information. Skyla (levonorgestrel)." Bayer Pharmaceutical Inc, West Haven, CT. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. "Product Information. Liletta (levonorgestrel)." Actavis Pharma, Inc., Parsippany, NJ. </p><p id="ref_7">7. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Mirena, Kyleena, Skyla &amp; Liletta - What's the difference?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about AfterPlan (levonorgestrel)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: contraceptives</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Mirena, Plan B, Plan B One-Step, Kyleena, ... +14 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Emergency Contraception</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to levonorgestrel: intrauterine device, oral tablet, subcutaneous implant</i></p><h3>General</h3><p>The most commonly reported adverse effects are alterations of menstrual bleeding patterns, nausea, abdominal/pelvic pain, headache/migraine, dizziness, fatigue, amenorrhea, ovarian cysts, genital discharge, acne/seborrhea, breast tenderness, and vulvovaginitis.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Irregular menstrual bleeding (67%), infrequent menstrual bleeding (up to 57%), ovarian cyst (31.2%), menstrual changes (up to 31.9%), decreased uterine bleeding (23.4%), prolonged menstrual bleeding (22%), vulvovaginitis (20.2%), amenorrhea (18.4%), genital discharge (up to 14.9%), heavier menstrual bleeding (13.8%),vaginal infections (13.6%), vulvovaginal infections (13.3%), lighter menstrual bleeding (12.5%), increased scheduled uterine bleeding (11.9%), breast tenderness (10.7%)</p><p><b>Common</b> (1% to 10%): Dysmenorrhea, breast pain/discomfort, upper genital tract infection, genital tract bleeding, pelvic inflammatory disease, endometritis, dyspareunia, pelvic discomfort/pain, delay of menses more than 7 days, vaginal discharge, bleeding not related to menses</p><p><b>Uncommon</b> (0.1% to 1%): Uterine spasm, cervicitis/Papanicolaou smear normal class II, change in vaginal secretion</p><p><b>Rare</b> (less than 0.1%): Uterine perforation</p><p><b>Frequency not reported</b>: Breast enlargement, vaginal candidiasis, changes in cervical erosion, changes in cervical secretion, ectopic pregnancy</p><p><b>Postmarketing reports</b>: Oligomenorrhea, irregular menstruation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 23.1%), abdominal/pelvic pain (up to 22.6%)</p><p><b>Common</b> (1% to 10%): Diarrhea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Abdominal distension</p><p><b>Frequency not reported</b>: Bloating, abdominal cramps<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (16.9%)</p><p><b>Common</b> (1% to 10%): Partial/complete IUS expulsion, weight increased</p><p><b>Uncommon</b> (0.1% to 1%): Edema, change in body weight</p><p><b>Very rare</b> (less than 0.01%): Face edema</p><p><b>Frequency not reported</b>: Decreased weight, sepsis, group A streptococcal sepsis</p><p><b>Postmarketing reports</b>: IUS breakage, procedural bleeding<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16.8%), dizziness (11.2%)</p><p><b>Common</b> (1% to 10%): Migraine</p><p><b>Postmarketing reports</b>: Stroke, syncope, IUS insertion related vasovagal reaction or seizure<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression/depressed mood, mood changes, mood swings, decreased libido, nervousness</p><p><b>Frequency not reported</b>: Changes in libido<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Acne/seborrhea (15%)</p><p><b>Common</b> (1% to 10%): Alopecia, hirsutism</p><p><b>Uncommon</b> (0.1% to 1%): Pruritus, eczema, pigmentation changes/hyperpigmentation</p><p><b>Rare</b> (less than 0.1%): Rash, urticaria</p><p><b>Frequency not reported</b>: Chloasma, melasma</p><p><b>Postmarketing reports</b>: Angioedema<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Postmarketing reports</b>: Increased blood pressure, arterial/venous thrombotic events, pulmonary emboli, deep vein thrombosis, stroke<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Benign/malignant liver tumors</p><p><b>Postmarketing reports</b>: Breast cancer<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Contact lens intolerance<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Diabetes mellitus<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Allergic reaction</p><p><b>Postmarketing reports</b>: Hypersensitivity reactions<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Kyleena (levonorgestrel)." Bayer Pharmaceutical Inc, West Haven, CT. </p><p id="ref_2">2. "Product Information. Mirena (levonorgestrel)." Berlex Laboratories, Richmond, CA. </p><p id="ref_3">3. "Product Information. Plan B (levonorgestrel)." Women's Capital Corporation, Bellevue, WA. </p><p id="ref_4">4. "Product Information. Skyla (levonorgestrel)." Bayer Pharmaceutical Inc, West Haven, CT. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_6">6. "Product Information. Liletta (levonorgestrel)." Actavis Pharma, Inc., Parsippany, NJ. </p><p id="ref_7">7. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Mirena, Kyleena, Skyla &amp; Liletta - What's the difference?</li>
</ul><h2>More about AfterPlan (levonorgestrel)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Drug class: contraceptives</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Emergency Contraception</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>